| (Values in U.S. Thousands) | Jan, 2023 | Jan, 2022 | Jan, 2021 | Jan, 2020 | Jan, 2023 |
| Sales | 35 | 135 | 0 | 0 | 0 |
| Sales Growth | -74.02% | unch | unch | unch | unch |
| Net Income | -2,068 | -1,882 | -1,582 | -2,292 | 0 |
| Net Income Growth | -9.86% | -19.00% | +30.98% | unch | unch |
Qscreen AI Inc (QAI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
QScreen AI Inc is an artificial intelligence (AI) company developing disruptive and cutting-edge tools for impairment testing and healthcare testing. Its proprietary technology uses facial and voice recognition to identify both cannabis and alcohol impairment by utilizing multiple features along with numerous different data points. The company is expanding its proprietary AI technology to screen for infectious diseases, and also to screen for psychiatric and/or brain disorders such as depression, dementia and Alzheimer's disease.es.
Fiscal Year End Date: 01/31